Hence, the mechanism by which EPS exerts these effects on breast cancer cells is most likely through activation of IKKβ-NFκB signaling and possibly also STAT1 activation as shown in our current model (Figure 8). The gene discussed is NFKB1; the disease is breast carcinoma.